Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels
- 1 April 1982
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (6), 1401-1404
- https://doi.org/10.1016/0002-9149(82)90350-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- RENAL, ADRENAL AND VASCULAR CHANGES DURING INHIBITION OF CONVERTING ENZYME WITH CAPTOPRILClinical and Experimental Pharmacology and Physiology, 1980
- Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension.Hypertension, 1980
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Relationships between the kallikrein-kinin and prostaglandin systemsLife Sciences, 1979
- The renal kallikrein-kinin system.Circulation Research, 1979
- Acute renal haemodynamic and renin‐angiotensin system responses to graded renal artery stenosis in the dog.The Journal of Physiology, 1979
- The Effect of the Converting Enzyme Inhibitor SQ 20.881 on Kinins, Renin‐Angiotensin‐Aldosterone and Catecholamines in Relation to Blood Pressure in Hypertensive PatientsActa Medica Scandinavica, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Cellular origin of urinary kallikreins.Journal of Histochemistry & Cytochemistry, 1976